Elgethun Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Sell
14,495
-182
-1% -$21.3K 0.26% 49
2026
Q1
$1.77M Buy
14,677
+2,776
+23% +$320K 0.29% 47
2025
Q4
$1.25M Buy
11,901
+35
+0.3% +$3.29K 0.22% 55
2025
Q3
$1.03M Sell
11,866
-113
-0.9% -$9.31K 0.19% 59
2025
Q2
$948K Buy
11,979
+41
+0.3% +$3.26K 0.19% 55
2025
Q1
$1.07M Sell
11,938
-167
-1% -$15.6K 0.24% 52
2024
Q4
$1.2M Buy
12,105
+49
+0.4% +$5.05K 0.29% 48
2024
Q3
$1.37M Sell
12,056
-78
-0.6% -$9.27K 0.32% 46
2024
Q2
$1.5M Sell
12,134
-76
-0.6% -$9.79K 0.38% 48
2024
Q1
$1.59M Buy
12,210
+5,224
+75% +$644K 0.4% 46
2023
Q4
$762K Sell
6,986
-98
-1% -$10.2K 0.22% 61
2023
Q3
$727K Buy
7,084
+4,355
+160% +$469K 0.22% 62
2023
Q2
$315K Buy
2,729
+12
+0.4% +$1.36K 0.09% 90
2023
Q1
$291K Buy
2,717
+13
+0.5% +$1.4K 0.09% 94
2022
Q4
$298K Buy
2,704
+42
+2% +$4.29K 0.11% 87
2022
Q3
$229K Sell
2,662
-37,744
-93% -$3.37M 0.09% 98
2022
Q2
$3.69M Sell
40,406
-534
-1% -$47.3K 1.43% 23
2022
Q1
$3.36M Buy
40,940
+445
+1% +$35.1K 1.14% 28
2021
Q4
$3.1M Sell
40,495
-2,228
-5% -$177K 1.08% 31
2021
Q3
$3.21M Sell
42,723
-791
-2% -$60.2K 1.11% 31
2021
Q2
$3.38M Buy
43,514
+33,341
+328% +$2.48M 1.16% 28
2021
Q1
$748K Buy
10,173
+1,357
+15% +$100K 0.29% 51
2020
Q4
$688K Buy
8,816
+1,014
+13% +$77.6K 0.29% 52
2020
Q3
$615K Hold
7,802
0.34% 47
2020
Q2
$511K Buy
7,802
+73
+0.9% +$5.5K 0.3% 48
2020
Q1
$567K Sell
7,729
-1,997
-21% -$157K 0.32% 52
2019
Q4
$844K Sell
9,726
-21
-0.2% -$1.73K 0.41% 42
2019
Q3
$783K Buy
9,747
+681
+8% +$54.6K 0.42% 45
2019
Q2
$725K Hold
9,066
0.4% 50
2019
Q1
$720K Buy
9,066
+52
+0.6% +$3.89K 0.42% 53
2018
Q4
$652K Sell
9,014
-530
-6% -$37.4K 0.45% 55
2018
Q3
$650K Hold
9,544
0.42% 56
2018
Q2
$550K Buy
9,544
+419
+5% +$23.6K 0.39% 63
2018
Q1
$474K Buy
9,125
+846
+10% +$45.7K 0.33% 71
2017
Q4
$445K Sell
8,279
-57
-0.7% -$3.16K 0.31% 67
2017
Q3
$509K Hold
8,336
0.37% 58
2017
Q2
$510K Sell
8,336
-137
-2% -$8.34K 0.4% 55
2017
Q1
$514K Hold
8,473
0.41% 52
2016
Q4
$476K Buy
+8,473
New +$496K 0.37% 52

Other funds holding MRK

Elgethun Capital Management's MRK Position: Q2 2026 in Review

Elgethun Capital Management reduced its Merck (MRK) stake by 1.2% in Q2 2026, selling an estimated $21.3K and leaving 14,495 shares worth $1.86M. The position accounts for 0.26% of the portfolio, ranked #49.

Elgethun Capital Management first reported a position in MRK in Q4 2016 and has held it in 39 quarters since. The position peaked at $3.69M in Q2 2022. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Elgethun Capital Management held 14,495 shares of Merck worth $1.86M as of Q2 2026.
  • Elgethun Capital Management sold 182 Merck shares in Q2 2026, an estimated $21.3K.
  • Merck made up 0.26% of Elgethun Capital Management's portfolio in Q2 2026, its #49 holding.
  • Elgethun Capital Management first reported a position in Merck in Q4 2016 and has held it in 39 quarters since.
  • Elgethun Capital Management's Merck position peaked at $3.69M in Q2 2022.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Elgethun Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.